3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
4
Stomach Neoplasms
3
Neoplasms
3
Esophageal Neoplasms
3
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Nasopharyngeal Carcinoma
2
Lung Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Neoplasms
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Pitfalls of PET Scan on Pediattic
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Nasopharyngeal Neoplasms
1
Myocarditis
1
Multiple Pulmonary Nodules
1
Mouth Neoplasms
1
Metastasis of Unknown Origin
1
Meningioma
1
Lymphoma, B-Cell
1
Lymphatic Metastasis
1
Intraabdominal Infections
1
Hematologic Neoplasms
1
Gynecological Tumors
1
Interventions
Surveys and Questionnaires
9
Cystectomy
6
Blood Specimen Collection
5
Neoadjuvant Therapy
4
Cystoscopy
4
Drug Therapy
3
avelumab
2
Urination
2
Urinary Diversion
2
Surgical Procedures, Operative
2
Radiotherapy
2
Pioglitazone
2
Microarray Analysis
2
Methods
2
Magnetic Resonance Spectroscopy
2
Interviews as Topic
2
Immunohistochemistry
2
Defecation
2
Biopsy
2
5-aminolevulinic acid hexyl ester
2
trastuzumab deruxtecan
1
sargramostim
1
pembrolizumab
1
erdafitinib
1
enfortumab vedotin
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Watchful Waiting
1
Urinary Sediment Analysis
1
Therapeutics
1
Specimen Handling
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Urinary Bladder Neoplasms
×
Positron Emission Tomography Computed Tomography
×
Clear all
NCT04053101
2025-09-18
TEP-Vessie
Institut Bergonié
Completed
130 enrolled
4 charts